All Circulars (28174)
Browse all regulatory circulars from India’s major stock exchanges and market regulator. Navigate by source using the buttons below or explore individual circulars in the grid.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE notifies listing and admission of new securities issued by four companies under ESOP/ESOS schemes, effective January 1, 2026. | |||||||||||||||
BSE notifies listing and admission of new securities issued by four companies under ESOP/ESOS schemes, effective January 1, 2026.
| |||||||||||||||
BSE announces listing and admission for trading of further securities issued under ESOP/ESOS schemes by Genus Power, Ivalue Infosolutions, … | |||||||||||||||
BSE announces listing and admission for trading of further securities issued under ESOP/ESOS schemes by Genus Power, Ivalue Infosolutions, Kirloskar Industries, and UTI AMC, effective January 01, 2026.
| |||||||||||||||
BSE announces listing of additional shares issued by four companies under employee stock option schemes, effective January 1, 2026. | |||||||||||||||
BSE announces listing of additional shares issued by four companies under employee stock option schemes, effective January 1, 2026.
| |||||||||||||||
Listing and trading permission for 16,61,000 equity shares issued on preferential basis pursuant to conversion of warrants, effective … | |||||||||||||||
Listing and trading permission for 16,61,000 equity shares issued on preferential basis pursuant to conversion of warrants, effective January 1, 2026.
| |||||||||||||||
16,61,000 new equity shares of NOVELIX PHARMACEUTICALS LIMITED listed on BSE effective January 1, 2026, issued through preferential … | |||||||||||||||
16,61,000 new equity shares of NOVELIX PHARMACEUTICALS LIMITED listed on BSE effective January 1, 2026, issued through preferential allotment via warrant conversion.
| |||||||||||||||
16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on BSE effective January 1, 2026, issued through preferential allotment … | |||||||||||||||
16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on BSE effective January 1, 2026, issued through preferential allotment via warrant conversion.
| |||||||||||||||
16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on BSE with effect from January 1, 2026, issued on preferential basis … | |||||||||||||||
16,61,000 equity shares of Novelix Pharmaceuticals Limited listed on BSE with effect from January 1, 2026, issued on preferential basis pursuant to warrant conversion.
| |||||||||||||||
BSE announces the listing of privately placed debt securities of Shriram Life Insurance Company Limited with INE227H08011 ISIN, effective … | |||||||||||||||
BSE announces the listing of privately placed debt securities of Shriram Life Insurance Company Limited with INE227H08011 ISIN, effective December 31, 2025.
| |||||||||||||||
NSE notifies listing of CEAT Limited's 7.20% non-convertible debentures maturing in 2030 on the capital market segment, effective January … | |||||||||||||||
NSE notifies listing of CEAT Limited's 7.20% non-convertible debentures maturing in 2030 on the capital market segment, effective January 01, 2026.
| |||||||||||||||
Announcement of listing of commercial papers from Capri Global Capital, Reliance Jio Infocomm, Lendingkart Finance, Ashoka Buildcon and debt … | |||||||||||||||
Announcement of listing of commercial papers from Capri Global Capital, Reliance Jio Infocomm, Lendingkart Finance, Ashoka Buildcon and debt securities from Satin Finserv on BSE Debt Segment effective December 31, 2025.
| |||||||||||||||